Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−35.16USD
−112.96 MUSD
1.16 MUSD
6.41 M
About Q32 Bio Inc.
Sector
Industry
CEO
Jodie P. Morrison
Website
Headquarters
Waltham
Employees (FY)
7
Founded
2017
FIGI
BBG00CTTJWQ9
Q32 Bio, Inc. operates as a clinical stage biotechnology company developing biologic therapeutics targeting potent regulators of the innate and adaptive immune systems to re-balance immunity in autoimmune and inflammatory diseases. It focuses on the IL-7 / TSLP receptor pathways and complement system, addressing immune dysregulation to help patients take back control of their lives. The company was founded by David Grayzel and Shelia Violette in 2017 and is headquartered in Waltham, MA.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of QTTB is 25.60 USD — it has increased by 0.04% in the past 24 hours. Watch Q32 Bio Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Q32 Bio Inc. stocks are traded under the ticker QTTB.
Q32 Bio Inc. is going to release the next earnings report on May 13, 2024. Keep track of upcoming events with our Earnings Calendar.
QTTB stock is 6.33% volatile and has beta coefficient of 0.52. Track Q32 Bio Inc. stock price on the chart and check out the list of the most volatile stocks — is Q32 Bio Inc. there?
QTTB earnings for the last quarter are −3.31 USD per share, whereas the estimation was −5.40 USD resulting in a 38.70% surprise. The estimated earnings for the next quarter are −1.42 USD per share. See more details about Q32 Bio Inc. earnings.
Yes, you can track Q32 Bio Inc. financials in yearly and quarterly reports right on TradingView.
QTTB stock has fallen by 9.64% compared to the previous week, the month change is a 23.85% rise, over the last year Q32 Bio Inc. has showed a 42.22% increase.
QTTB net income for the last quarter is −16.12 M USD, while the quarter before that showed −32.95 M USD of net income which accounts for 51.09% change. Track more Q32 Bio Inc. financial stats to get the full picture.
Today Q32 Bio Inc. has the market capitalization of 305.28 M, it has decreased by 11.88% over the last week.
No, QTTB doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, QTTB shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Q32 Bio Inc. stock right from TradingView charts — choose your broker and connect to your account.
QTTB reached its all-time high on Feb 27, 2019 with the price of 572.40 USD, and its all-time low was 8.24 USD and was reached on Nov 16, 2023. View more price dynamics on QTTB chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
As of May 6, 2024, the company has 7.00 employees. See our rating of the largest employees — is Q32 Bio Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Q32 Bio Inc. technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Q32 Bio Inc. stock shows the neutral signal. See more of Q32 Bio Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on Q32 Bio Inc. future price: according to them, QTTB price has a max estimate of 50.00 USD and a min estimate of 45.00 USD. Watch QTTB chart and read a more detailed Q32 Bio Inc. stock forecast: see what analysts think of Q32 Bio Inc. and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Q32 Bio Inc. EBITDA is −90.82 M USD, and current EBITDA margin is −7.92 K%. See more stats in Q32 Bio Inc. financial statements.